The Effect of Contrast Material on Transcranial Doppler Evaluation of Normal Middle Cerebral Artery Peak Systolic Velocity

References

1. ↵
   Carter LP, Grahm T, Zabramski JM, et al. Postoperative monitoring of cerebral blood flow in patients harboring intracranial aneurysms. Neurol Res 1990;12:214-218

   PubMed
2. ↵
   Sanker P, Richard KE, Weigl HC, Klug N, van Leyen K. Transcranial Doppler sonography and intracranial pressure monitoring in children and juveniles with acute brain injury or hydrocephalus. Childs Nerv Syst 1991;7:391-393

   CrossRefPubMed
3. ↵
   Goertler M, Kross R, Baeumer M, et al. Diagnostic impact and prognostic relevance of early contrast-enhanced transcranial color-coded duplex sonography in acute stroke. Stroke 1998;29:955-962

   Abstract/FREE Full Text
4. ↵
   Nabavi DG, Droste DW, Kemeny V, Schulte-Altedorneburg G, Weber S, Ringelstein EB. Potential and limitations of echocontrast-enhanced ultrasonography in acute stroke patients: a pilot study. Stroke 1998;29:949-954

   Abstract/FREE Full Text
5. ↵
   Bogdahn U, Frohlich T, Becker G, et al. Vascularization of primary central nervous system tumors: detection with contrast-enhanced transcranial color-coded real-time sonography. Radiology 1994;192:141-148

   CrossRefPubMed
6. ↵
   Chadduck WM, Crabtree HM, Blankenship JB, Adametz J. Transcranial Doppler for evaluation of shunt malfunction in pediatric patients. Childs Nerv Syst 1991;7:27-30

   CrossRefPubMed
7. Ophir J, Parker KJ. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 1989;15:319-333

   CrossRefPubMedWeb of Science
8. Murphy KJ, Bude RO, Dickinson LD, Rubin JM. Use of intravenous contrast material in transcranial sonography. Acad Radiol 1997;4:577-582

   CrossRefPubMed
9. Ries F, Honisch C, Lambertz M, Schlief R. A transpulmonary contrast medium enhances the transcranial Doppler signal in humans. Stroke 1993;24:1903-1909

   Abstract/FREE Full Text
10. Rosenkranz K, Zendel W, Langer R, et al. Contrast-enhanced transcranial Doppler US with a new transpulmonary echo contrast agent based on saccharide microparticles. Radiology 1993;187:439-443

    PubMed
11. ↵
    Petrick J, Zomack M, Schlief R. An investigation of the relationship between ultrasound echo enhancement and Doppler frequency shift using a pulsatile arterial flow phantom. Invest Radiol 1997;32:225-235

    CrossRefPubMed
12. ↵
    Rubin JM, Bude RO, Carson PL, Bree RL, Adler RS. Power Doppler US: a potentially useful alternative to mean frequency based color Doppler US. Radiology 1994;190:853-856

    CrossRefPubMedWeb of Science
13. ↵
    Forsberg F, Liu JB, Burns PN, Merton DA, Goldberg BB. Artifacts in ultrasonic contrast agent studies. J Ultrasound Med 1994;13:357-365

    Abstract
14. ↵
    Abildgaard A, Egge TS, Klow NE, Jakobsen JA. Use of sonicated albumin (Infoson) to enhance arterial spectral and color Doppler imaging. Cardiovasc Intervent Radiol 1996;19:265-271

    CrossRefPubMedWeb of Science
15. ↵
    Gutberlet M, Venz S, Neuhaus R, et al. Contrast agent enhanced duplex ultrasonography: visualization of the hepatic artery after orthotopic liver transplantation. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1997;166:411-416

    PubMed
16. ↵
    Gutberlet M, Venz S, Zendel W, Hosten N, Felix R. Do ultrasonic contrast agents artificially increase maximum Doppler shift? in vivo study of human common carotid arteries. J Ultrasound Med 1998; 17:97-102

    Abstract
17. ↵
    Albrecht T, Urbank A, Mahler M, et al. Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: preliminary experience. Radiology 1998;207:339-347

    CrossRefPubMedWeb of Science